Andra AP fonden Raises Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Andra AP fonden lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 431.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 50,500 shares of the company's stock after purchasing an additional 41,000 shares during the period. Andra AP fonden's holdings in GE HealthCare Technologies were worth $3,948,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in GEHC. Capital Performance Advisors LLP acquired a new position in GE HealthCare Technologies during the third quarter worth $26,000. Ashton Thomas Securities LLC acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at about $26,000. Darwin Wealth Management LLC acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at about $31,000. Continuum Advisory LLC raised its position in shares of GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after buying an additional 168 shares during the last quarter. Finally, Bank of Jackson Hole Trust acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at about $32,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Up 1.4 %

GEHC stock traded up $1.17 during midday trading on Friday, reaching $86.58. 4,075,712 shares of the company were exchanged, compared to its average volume of 2,984,066. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80. The stock's 50-day simple moving average is $86.77 and its 200 day simple moving average is $86.16. The company has a market cap of $39.59 billion, a price-to-earnings ratio of 20.00, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13.

Remove Ads

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of recent research reports. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their target price for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Citigroup upped their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a report on Thursday, February 13th. Finally, Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of "Moderate Buy" and a consensus price target of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.